Immunovant, Inc.

IMVT · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
131
SEC Filings

Business Summary

PART I Overview Immunovant is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Our focus is on developing IMVT-1402, a potentially best-in-class inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of tot...

Next Earnings

Q2 FY2026 — expected 2026-09-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionIMVTdiscussed_in_filing Cybersecurity
topic_mentionIMVTdiscussed_in_filing Trusted Computing
topic_mentionIMVTdiscussed_in_filing Blockchain & Crypto
topic_mentionIMVTdiscussed_in_filing Capital Expenditure
topic_mentionIMVTdiscussed_in_filing Supply Chain
topic_mentionIMVTdiscussed_in_filing Regulation
topic_mentionIMVTdiscussed_in_filing Healthcare & Bio
topic_mentionIMVTdiscussed_in_filing Sovereign & Government
topic_mentionIMVTdiscussed_in_filing Cybersecurity
topic_mentionIMVTdiscussed_in_filing Trusted Computing
topic_mentionIMVTdiscussed_in_filing Blockchain & Crypto
topic_mentionIMVTdiscussed_in_filing Capital Expenditure
topic_mentionIMVTdiscussed_in_filing Supply Chain
topic_mentionIMVTdiscussed_in_filing Regulation
topic_mentionIMVTdiscussed_in_filing Healthcare & Bio
topic_mentionIMVTdiscussed_in_filing Sovereign & Government
topic_mentionIMVTdiscussed_in_filing Cybersecurity
topic_mentionIMVTdiscussed_in_filing Trusted Computing
topic_mentionIMVTdiscussed_in_filing Blockchain & Crypto
topic_mentionIMVTdiscussed_in_filing Capital Expenditure

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-05-292025-03-310001764013-25-000092EDGAR99K words
2024-05-292024-03-310001764013-24-000109EDGAR—
2023-05-222023-03-310001764013-23-000065EDGAR—
2022-06-082022-03-310001764013-22-000059EDGAR—
2021-06-012021-03-310001764013-21-000052EDGAR—
2020-06-292020-03-310000950123-20-006444EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-02-062025-12-310001764013-26-000011EDGAR20K words
2025-11-102025-09-300001764013-25-000149EDGAR—
2025-08-112025-06-300001764013-25-000129EDGAR—
2025-02-062024-12-310001764013-25-000026EDGAR—
2024-11-072024-09-300001764013-24-000184EDGAR—
2024-08-062024-06-300001764013-24-000148EDGAR—
2024-02-122023-12-310001764013-24-000026EDGAR—
2023-11-092023-09-300001764013-23-000133EDGAR—
2023-08-102023-06-300001764013-23-000092EDGAR—
2023-02-032022-12-310001764013-23-000022EDGAR—
2022-11-042022-09-300001764013-22-000140EDGAR—
2022-08-052022-06-300001764013-22-000085EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-060001764013-26-000010EDGAR3K words
2025-12-120001193125-25-317577EDGAR—
2025-12-110001193125-25-314994EDGAR—
2025-11-210001764013-25-000153EDGAR—
2025-11-100001764013-25-000148EDGAR—
2025-09-030001764013-25-000136EDGAR—
2025-08-280001764013-25-000132EDGAR—
2025-08-110001764013-25-000128EDGAR—
2025-07-290001764013-25-000121EDGAR—
2025-05-290001764013-25-000091EDGAR—

131 total filings indexed. 103 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001764013
TickerIMVT
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 17863affcec1fac15070e7d27314a314237a12d6dffe632be2b130608af31c46
parent: e98a26578fac5aad580ae1313395613a0f78c79421901de7c76dad6a4b120d6b
content hash: 84bfb8033f1537525cbbaaf926521dcb5d8cc0715dfa7c5a7a60d54de0a998e3
signed: 2026-04-13T04:45:41.054Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf